Back to Results
First PageMeta Content
Health / Hepatitis / Hepatitis C / Protease inhibitors / Interferon / Ribavirin / Hepatitis C and HIV co-infection / Hepatocellular carcinoma / Viral hepatitis / Medicine / Biology / Antivirals


New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi
Add to Reading List

Document Date: 2014-09-15 11:42:23


Open Document

File Size: 63,11 KB

Share Result on Facebook

Company

Hepatitis C Trust / Bristol-Myers Squibb / /

Country

United Kingdom / /

IndustryTerm

treatment of HCV / treatment for hepatitis C / /

MedicalCondition

fatigue / primary liver cancer A / headache / infection / chronic liver disease / infections / nausea / chronic hepatitis C / hepatitis C / HCV / /

Person

Janna Lawrence Daclatasvir / Charles Gore / /

Position

chief executive / /

Product

peginterferon / ribavirin / /

PublishedMedium

The Pharmaceutical Journal / /

Technology

genotype / /

SocialTag